19 February 2020
Human trials for one or two of the most promising vaccine candidates could begin in three or four months, WHO chief scientist Soumya Swaminathan said.
She added that WHO experts, who gathered for a two-day forum in Geneva earlier this week, have discussed possible timeframes for determining what vaccine should be a priority.
In her opinion, the new vaccine expected to be ready in 12-18 months.
On February 11 and 12, Geneva hosted a two-day global forum aimed at establishing measures to fight the novel coronavirus. The forum brings together around 400 experts from across the world. The main goal of the forum is to identify knowledge gaps and research priorities in order to produce scientific information and medical products most needed to minimize the impact of the outbreak.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
InFigures European Pharma Hotspots 2024
05 November 2024
Federal project to combat hepatitis C will be launched in 2025
05 November 2024
Federal project to combat hepatitis C will be launched in 2025
01 November 2024
Domestic drugs now make up 60% of Russian pharmacies
01 November 2024